Connection

JOHN LYDON to Mammary Neoplasms, Experimental

This is a "connection" page, showing publications JOHN LYDON has written about Mammary Neoplasms, Experimental.
Connection Strength

0.847
  1. Hormone dependence in premalignant mammary progression. Cancer Res. 2003 Mar 01; 63(5):1067-72.
    View in: PubMed
    Score: 0.186
  2. Hippo-TAZ signaling is the master regulator of the onset of triple-negative basal-like breast cancers. Proc Natl Acad Sci U S A. 2022 07 19; 119(29):e2123134119.
    View in: PubMed
    Score: 0.178
  3. Progesterone's role in mammary gland development and tumorigenesis as disclosed by experimental mouse genetics. Breast Cancer Res. 2002; 4(5):191-6.
    View in: PubMed
    Score: 0.178
  4. Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function. Cancer Res. 1999 Sep 01; 59(17):4276-84.
    View in: PubMed
    Score: 0.146
  5. The PR status of the originating cell of ER/PR-negative mouse mammary tumors. Oncogene. 2016 08 04; 35(31):4149-54.
    View in: PubMed
    Score: 0.113
  6. Role of the progesterone receptor (PR) in susceptibility of mouse mammary gland to 7,12-dimethylbenz[a]anthracene-induced hormone-independent preneoplastic lesions in vitro. Cancer Lett. 2002 Dec 15; 188(1-2):47-52.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.